Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.701
-0.043 (-5.77%)
Feb 27, 2025, 4:00 PM EST
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $54.75 million as of February 27, 2025. Its market cap has increased by 57.70% in one year.
Market Cap
54.75M
Enterprise Value
34.08M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 54.75M, an increase of 12.42%. That is a compound annual growth rate of 1.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.19B |
| SS Innovations International | 1.82B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 864.81M |
| Elite Pharmaceuticals | 522.39M |
| Glass House Brands | 462.22M |
| CytoDyn | 377.07M |
| Northwest Biotherapeutics | 345.91M |